Promotion, prediction, and prevention of progression in diabetic nephropathy

Danish Medical Bulletin

Volumn 45, Issue 4, 1998, Pages 354-369

  Rossing, Peter ^a,b  

^a STENO DIABETES CENTER   (Denmark)

^b Steno Diabetes Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOFIBRIC ACID; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; SIMVASTATIN;

DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULUS FILTRATION; HEALTH PROMOTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; PREDICTION; PROGNOSIS; PROTEINURIA; REVIEW; TREATMENT PLANNING;

DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; INCIDENCE; PROGNOSIS;

EID: 0031705799     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (200)

1. Agodoa LY, Eggers PW (1995) Renal replacement therapy in the united states: Data from the united states renal data system. Am J Kidney Dis 25: 119-133.
2. American Diabetes Association (1993) Treatment of Hypertension in Diabetes. Diabetes Care 16: 1394-1401.
3. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496-501.
4. Anderson S, Rennke HG, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000.
5. Anderson S, Rennke HG, Garcia DL, Brenner BM (1989) Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36: 526-536.
6. Anderson S (1991) Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass. Hypertension 17: 288-295.
7. Appel LJ, Miller ER, Seidler AJ, Whelton PK (1993) Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 53: 1429-1438.
8. Apperloo AJ, de Zeeuw D, de Jong PE (1994) Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int 45 (suppl. 45): S174-S178.
9. Bakris GL, Barnhill BW, Sadler R (1992) Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 41: 912-919.
10. Bakris GL, Copley JB, Vicknair N, Leugans S (1995) Effect of nondihydropyridine calcium antagonists (NDCAs) on progression of nephropathy from non-insulin dependent diabetes (NIDDM): a five year follow-up study. J Am Soc Nephrol 6: 446 (Abstract).
11. Bangstad H-J, Østerby R, Dahl-Jørgensen K, Berg K, Hartmann A, Hanssen KF (1994) Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37: 483-490.
12. Berglund J, Lins L-E, Lins P-E (1985) Metabolic and blood pressure monitoring in diabetic renal failure. Acta Med Scand 218: 401-408.
13. Bergström J, Kullberg CE, Larsson L, Dinesen B, Little RR, Arnqvist HJ (1995) Large differences in HbAJr values between laboratories of diabetic complications studies. Diabetologia 38: A184 (Abstract).
14. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M (1986) Beneficial effect of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293: 471-474.
15. Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M (1992) Renal protective effect of enalapril in diabetic nephr opathy. Br Med J 304: 339-343.
16. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg B, Ludvigsson J (1994) Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330: 15-18.
17. Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590-596.
18. Borch-Johnsen K, Nørgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T et al. (1992) Is diabetic nephropathy an inherited complication? Kidney Int 41: 719-722.
19. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE (1993) Is screening and intervention for rnicroalbuminuria worthwhile in patients with insulin dependent diabetes. Br Med J 306: 1722-1725.
20. Borch-Johnsen K, Kreiner S (1987) Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 294: 1651-1654.
21. Brenner BM (1983) Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647-655.
22. Bretzel RG, Bollen CC, Maeser E, Federlin KF (1993) Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients. Am J Kidney Dis 6: 53-64.
23. Breyer JA, McGill JB, Nahman NS (1993) Predictors of the rate of progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. J Am Soc Nephrol 4: 301 (Abstract).
24. Brown SA, Walton CL, Crawford P, Bakris GL (1993) Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria. Kidney Int 43: 1210-1218.
25. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321.
26. Bröchner-Mortensen J, Giese J, Rossing N (1969) Renal inulin clearance versus total plasma clearance of 51 Cr-EDTA. Scand J Clin Lab Invest 23: 301-305.
27. Bröchner-Mortensen J (1972) A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30: 271-274.
28. Bröchner-Mortensen J, Rödbro P (1976) Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 36: 35-45.
29. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet ii: 757-761.
30. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644.
31. Canter DA, Texter MJ, McLain RW (1994) Short report: Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents. J Hypertens 12: 491-494.
32. Chan JCN, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R (1992) Comparison of enalapril and nifedipine in treating non-insulin dependent diabetics associated with hypertension: one year analysis. Br Med J 305: 981-985.
33. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE et al. (1991) Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. JAMA 265: 614-617.
34. Christiansen JS (1978) Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1: 146-149.
35. Conway J, Coats A, Radaelli A (1990) Ambulatory blood pressure in relation to drug treatment and clinical trials. J Hypertens 8: S83-S85.
36. Cortes P, Riser BL, Zhao X, Narins RG (1994) Glomerular volume expansion and mesangial cell mechanical strain: Mediators of glomerular pressure injury. Kidney Int 45 (suppl. 45): 11-16.
37. Dansk Nefrologisk Selskab (1995) Landsregister for patienter i aktiv behandling for nyresvigt. Dansk Nefrologisk Selskab 1.
38. De Caterina R, Caprioli R, Giannessi D, Sicari R, Galli C, Lazzerini G et al. (1993) n-3 Fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int 44: 843-850.
39. De Caterina R, Endres S, Kristensen SD, Schmidt EB (1994) n-3 fatty acids and renal diseases. Am J Kidney Dis 24: 397-415.
40. Deckert T, Poulsen JE, Larsen M (1978) Prognosis of diabetics with diabetes onset before the age of thirtyone. I. Survival, causes of death and complications. Diabetologia 14: 363-370.
41. Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M (1988) Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33: 100-106.
42. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219-226.
43. Demaire BK, Bakris GL (1990) Effects of different classes of calcium antagonist on proteinuria in diabetic subjects. Ann Intern Med 113: 987-988.
44. Donadio JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE (1994) A controlled trial of fish oil in IgA nephropathy. N Engl J Med 331: 1194-1199.
45. Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD (1993) Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int 43: 808-814.
46. Dyerberg J, Bang HO (1979) Hemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet ii: 433-435.
47. Eggers PW (1988) Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 318: 223-229.
48. Elving LD, Wetzels JFM, van Lier HJJ, de Nobel E, Berden JHM (1994) Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Diabetologia 37: 604-609.
49. Epstein M (1995) Calcium antagonists should continue to be used for first-line treatment of hypertension. Arch Intern Med 155: 2150-2156.
50. Feldt-Rasmussen B, Dinesen B, Deckert M (1985) Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Cin Lab Invest 45: 539-544.
51. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Juel Christensen N, Bent-Hansen L et al. (1987) Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes, mellitus. Diabetologia 30: 610-617.
52. Feldt-Rasmussen B (1989) Microalbuminuria and clinical nephropathy in type 1 (insulin-dependent) diabetes mellitus: pathophysiological mechanisms and intervention studies. Dan Med Bull 36: 405-415.
53. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I (1988) Serial micro-puncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 82: 322-330.
54. Fujikawa M, Yamazaki K, Hamazaki T, Wakaki K, Koizumi F, Yano S et al. (1994) Effect of eicosapentaenoic acid ethyl ester on albuminuria in streptozotocin-induced diabetic rats. J Nutr Sci Vitaminol 40: 49-61.
55. Glassock RJ, Hirschman GH, Striker GE (1991) Workshop on the use of renal biopsy in research on diabetic nephropathy: A summary report. Am J Kidney Dis 18: 589-592.
56. Haines AP (1986) Fish oil supplement in diabetics. Thromb Res 43: 644-655.
57. Hamazaki T, Takazakura E, Osawa K, Urakaze M, Yano S (1990) Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester. Lipids 25: 541-545.
58. Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving H-H (1995) Increased glomerular filtration rate after withdrawal of long-term anti-hypertensive treatment in diabetic nephropathy. Kidney Int 47: 1726-1731.
59. Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving H-H (1996) Circadian rhythm of systemic blood pressure and albuminuria in diabetic nephropathy. Kidney Int 50: 579-585.
60. Hansen KW, Mau Pedersen M, Marshall SM, Christiansen JS, Mogensen CE (1992) Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia 35: 1074-1079.
61. Hansen KW, Poulsen PL, Mogensen CE (1994) Ambulatory blood pressure and abnormal albuminuria in type 1 diabetic patients. Kidney Int 45 (suppl 45): S134-S140.
62. Hasslacher C, Stech W, Wahl P, Ritz E (1985) Blood pressure and metabolic control as risk factors for nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 28: 6-11.
63. Holdaas H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P et al. (1991) Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J Intern Med 229: 163-170.
64. Hommel E, Mathiesen ER, Giese J, Nielsen MD, Schütten HJ, Parving H-H (1989) On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy. Scand J Clin Lab Invest 49: 537-544.
65. Hommel E, Andersen P, Gall M-A, Nielsen FS, Jensen B, Rossing P et al. (1992) Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia 35: 447-451.
66. Hommel E, Jensen B, Parving H-H (1995) Long term effect of captopril on kidney function in normotensive insulin dependent diabetic patients (IDDM) with diabetic nephropathy. J Am Soc Nephrol 6: 450(Abstract).
67. Hostetter TH, Troy JL, Brenner BM (1981) Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415.
68. Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomeru-lopathies. Am J Med 72: 375-380.
69. Jacobsen P, Tarnow L, Rossing P, Cambien F, Lecerf L, Poirier O et al. (1995) The insertion/deletion (I/D) polymorphism in the angiotensin-I-converting enzyme (ACE) gene predicts the progression of diabetic nephropathy during ACE inhibition (ACEI) in insulin dependent diabetic (IDDM) patients. J Am Soc Nephrol 6: 450(Abstract).
70. Jensen PK, Steven K, Blæhr H, Christiansen JS, Parving H-H (1986) The effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29: 490-495.
71. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk-factors. Diabetologia 30: 144-148.
72. Jensen T, Stender S, Goldstein K, Holmer G, Deckert T (1989) Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N Engl J Med 321: 1572-1577.
73. Joint National Committee on Detection E (1993) The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Intern Med 153: 154-183.
74. Jungmann E, Haak T, Malanyn M, Mortasawi N, Scherberich J, Usadel KH (1992) Comparative study on renal effects of nitrendipine vs enalapril in microalbuminuric patients with type 1 diabetes mellitus. Diabetologia 35: A149(Abstract).
75. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF (1988a) Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33: 667-672.
76. Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF (1988b) Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62: 367-374.
77. Kasiske BL, Kalil R, Ma JZ, Liao M, Keane WF (1993) Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118: 129-138.
78. Kasiske BL, O'Donnell MP, Kim Y, Atluru D, Keane WF (1994) Cholesterol synthesis inhibitors inhibit more than cholesterol synthesis. Kidney Int 45: S51-S53.
79. Keane WF, O'Donnell MP, Kasiske BL, Kim Y (1993) Oxidative modification of low-density lipoproteins by mesangial cells. J Am Soc Nephrol 4: 187-194.
80. Kiberd BA, Jindal KK (1995) Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation. Br Med J 311: 1595-1599.
81. Kjekshus J, Pedersen TR (1995) Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 76: 64C-68C.
82. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW et al. (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease, N Engl J Med 330: 877-884.
83. Knowles HCJ (1971) Long term juvenile diabetes treated with unmeasured diet. Trans Assoc Am Physicians 84: 95-101.
84. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T (1987) Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes 36: 205-209.
85. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in Type 1 diabetes. Am J Med 78: 785-794.
86. Krolewski AS, Warram JH, Christlieb AR (1994) Hypercholesterolemia - A determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 45 (suppl. 45): S125-S131.
87. Kromhout D, Bosschieter EB, de Lezenne Coulander C (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312: 1205-1209.
88. Laffel L, Gans JD, McGill JB (1993) Captopril decreases the rate of progression of renal disease in normotensive, insulin-dependent diabetes mellitus (IDDM) patients with microalbuminuria. J Am Soc Nephrol 4: 304(Abstract).
89. Lam KS, Cheng IKP, Janus ED, Pang RWC (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604-609.
90. Laurell C-B (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies . Anal Biochem 15: 45-52.
91. Lewis E, Hunsicker L, Bain R, Rhode R (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462.
92. Maki DD, Ma JZ, Louis TA, Kasiske BL (1995) Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 155: 1073-1080.
93. Mallick NP, Jones E, Selwood N (1995) The European (European Dialysis and Transplantation Association-European Renal Association) Registry. Am J Kidney Dis 25: 176-187.
94. Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion., Immunochemistry 2: 235-254.
95. Manske CL, Wang Y, Thomas W (1995) Mortality of cadaveric kidney transplantation versus combined kidney-pancreas transplantation in diabetic patients. Lancet 346: 1658-1662.
96. Marre M, Chatellier G, Leblanc H, Guyenne T-T, Ménard J, Passa P (1988) Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 297: 1092-1095.
97. Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T (1989) Improved survival in patients with diabetic nephropathy. Diabetologia 32: 884-886.
98. Mathiesen ER, Rønn B, Jensen T, Storm B, Deckert T (1990) Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 39: 245-249.
99. Mathiesen ER, Hommel E, Giese J, Parving H-H (1991) Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. Br Med J 303: 81-87.
100. Mathiesen ER, Feldt-Rasmussen B, Hommel E, Deckert T, Parving H-H (1992) A 5 year study of glomerular filtration rate in normotensive IDDM patients with microalbuminuria. Diabetologia 35 (suppl 1): A60(Abstract).
101. Melbourne Diabetic Nephropathy Study Group (1991) Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 302: 210-216.
102. Microalbuminuria Collaborative Study Group UK (1993) Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Br Med J 306: 1235-1239.
103. Microalbuminuria Collaborative Study Group U (1995) Intensive therapy and progressive to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Br Med J 311: 973-977.
104. Miles DW, Mogensen CE, Gundersen HJG (1970) Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 26: 5-11.
105. Mimran A, Insua A, Ribstein J, Bringer J, Monnier L (1988) Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care 11: 850-853.
106. Modification of Diet in Renal Disease Study group., Levey AS, Gassman J, Hall PM, Walker WG (1991) Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. J Am Soc Nephrol 1: 1087-1094.
107. Mogensen CE (1976) Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 36: 383-388.
108. Mogensen CE (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685-688.
109. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E et al. (1985) Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 9: 85-95.
110. Mogensen CE (1992) Angiotensin converting enzyme inhibitors and diabetic nephropathy. Br Med J 304: 327-328.
111. Mogensen CE (1995) Diabetic renal disease: the quest for normotension - and beyond. Diabetic Med 12: 756-769.
112. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving H-H, Passa P et al. (1995) Prevention of diabetic renal disease with special reference to micro-albuminuria. Lancet 346: 1080-1084.
113. Moorhead JF, El-Nahas M, Chan MK, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitiai disease. Lancet ii: 1309-1311.
114. Morelli E, Loon N, Meyer TW, Peters W, Myers BD (1990) Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39: 76-82.
115. 1c by thin-layer isoelectric focusing. J Chromatogr 182: 325-333.
116. Mulec H, Johnsen SA, Björck S (1990) Relation between serum cholesterol and diabetic nephropathy. Lancet 335: 1537-1538.
117. Mulec H, Johnsen SA, Wiklund D, Björck S (1993) Cholesterol: a renal risk factor in diabetic nephropathy? Am J Kidney Dis 22: 196-201.
118. Mulec H, Blohmé G, Grände B, Björck S (1995a) Progression of overt diabetic nephropathy (DN); role of metabolic control. J Am Soc Nephrol 6: 453(Abstract).
119. Mulec H, Blohmé G, KuIIenberg G, Nyberg G, Björck S (1995b) Latent over-hydration and nocturnal hypertension in diabetic nephropathy. Diabetologia 38: 216-220.
120. Mühlhauser I, Sawicki PT, Berger M (1986) Cigarette smoking as a risk factor for macroproteinuria and proliferative retinopathy in Type 1 (insulin-dependent) diabetes. Diabetologia 29: 500-502.
121. Myers BD, Winetz JA, Chui F, Michaels AS (1982) Mechanisms of proteinuria in diabetic nephropathy: A study of glomerular barrier function. Kidney Int 21: 633-641.
122. Nielsen S, Schmitz O, Møller N, Pørksen N, Klausen IC, Alberti KGMM et al. (1993) Renal function and insulin sensitivity during simvastatin treatment in Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 36: 1079-1086.
123. Nordén G, Nyberg G (1984) Smoking and diabetic nephropathy. Acta Med Scand 215: 257-261.
124. Nyberg G, Blohmé G, Nordén G (1987) Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia 30: 82-86.
125. Nørgaard K, Jensen T, Christensen P, Feldt-Rasmussen B (1993) A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension. Blood Pressure 2: 301-308.
126. O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH (1993) Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study. Journal of Human Hypertension 7: 333-339.
127. Parving H-H, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR (1981) A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20: 457-461.
128. Parving H-H, Andersen AR, Smidt UM, Christiansen JS, Oxenbøll B, Svendsen PA (1983a) Diabetic nephropathy and arterial hypertension: the effect of antihypertensive treatment. Diabetes 32 (suppl 2): 83-87.
129. Parving H-H, Andersen AR, Smidt UM, Oxenbøll B, Edsberg B, Christiansen JS (1983b) Diabetic nephropathy and arterial hypertension. Diabetologia 24: 10-12.
130. Parving H-H, Andersen AR, Smidt UM, Svendsen PA (1983c) Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i: 1175-1179.
131. Parving H-H, Kastrup J, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS (1984) Impaired autoregulation of glomerular filtration rate in Type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27: 547-552.
132. Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443-1447.
133. Parving H-H, Hommel E, Mathiesen ER, Skøtt P, Edsberg B, Bahnsen M et al. (1988a) Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes. Br Med J 296: 156-160.
134. Parving H-H, Hommel E, Smidt UM (1988b) Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 297: 1086-1091.
135. Parving H-H (1990) Low-protein diet and progression of renal disease in diabetic nephropathy (letter). Lancet 335: 411.
136. Parving H-H (1991) Protein restriction and renal failure in diabetes mellitus. N Engl J Med 324: 1743-1744.
137. Parving H-H, Rossing P, Hommel E, Smidt UM (1992) Renal protective effects of captopril and metoprolol in diabetic nephropathy. J Am Soc Nephrol 3: 337(Abstract).
138. Parving H-H, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielsen FS et al. (1993) Effective Antihypertensive Treatment Postpones Renal Insufficiency in Diabetic Nephropathy. Am J Kidney Dis 22: 188-195.
139. Parving H-H, Rossing P, Hommel E, Smidt UM (1995) Angiotensin converting enzyme inhibition in diabetic nephropathy: ten years experience. Am J Kidney Dis 26: 99-107.
140. Parving H-H, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P (1996a) Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int 49: 1778-1782.
141. Parving H-H, Tarnow L, Rossing P (1996b) The angiotensin-converting enzyme gene and its inhibition in diabetic nephropathy. Current Opinion in Nephrology and Hypertension 3: 315-321.
142. Parving H-H, Østerby R, Anderson PW, Hsueh WA (1996c) Diabetic nephropathy. In: Brenner BM (eds) The Kidney. 5th Ed. Saunders, Philadelphia, pp 1864-1892.
143. Parving H-H, Hommel E (1989) Prognosis in diabetic nephropathy. Br Med J 299: 230-233.
144. Parving H-H, Rossing P (1994) The use of antihypertensive agents in prevention and treatment af diabetic nephropathy. Current Opinion in Nephroiogy and Hypertension 3: 292-300.
145. Peterson JC, Adler S, Burkart JM, Greene T, Herbert LA, Hunsicker LG et al. (1995) Blood pressure control, proteinuria, and the progression of renal disease. Modification of diet in renal disease study. Ann Intern Med 123: 754-762.
146. Rabelink AJ, Hené RJ, Erkelens DW, Joles JA, Koomans HA (1990) Partial remission of nephrotic syndrome in patients on long-term simvastatin. Lancet 335: 1045-1046.
147. Ravid M, Neumann L, Lishner M (1995) Plasma lipids and the progression of nephropathy in diabetes mellitus type II: Effect of ACE inhibitors. Kidney Int 47: 907-910.
148. Reddi AS, Ramamurthi R, Miller M, Dhuper S, Lasker N (1991) Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats. Biochem Med Metab Biol 45: 119-131.
149. Remuzzi G, Bertani T (1990) Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?. Kidney Int 38: 384-394.
150. Rossing P, Borch-Johnsen K, Parving H-H (1993a) Risk factors for development of incipient and overt diabetic nephropathy in IDDM patients. J Am Soc Nephrol 4: 308(Abstract).
151. Rossing P, Hommel E, Smidt UM, Parving H-H (1993b) Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42: 715-719.
152. Rossing P, Astrup A-S, Smidt UM, Parving H-H (1994a) Monitoring kidney function in diabetic nephropathy. Diabetologia 37: 708-712.
153. Rossing P, Hommel E, Smidt UM, Parving H-H (1994b) Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 37: 511-516.
154. Rossing P, Hommel E, Smidt UM, Parving H-H (1994c) Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 45 (suppl. 45): S145-S149.
155. Rossing P, Rossing K, Jacobsen P, Parving H-H (1995) Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 44: 739-743.
156. Rossing P, Hansen BV, Nielsen FS, Myrup B, Holmer G, Parving H-H (1996a) Fish oil in diabetic nephropathy. Diabetes Care 19: 1214-1219.
157. Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H (1996b) Predictors of mortality in insulin dependent diabetes: 10 year follow up study. Br Med J 313: 779-784.
158. Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving H-H (1997) Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes 46: 481-487.
159. Rudberg S, Ullman E, Dahiquist G (1993) Relationship between early metabolic control and the development of microalbuminuria - a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 1309-1314.
160. Sawicki PT, Mühlhauser I, Didjurgeit U, Baumgartner A, Bender R, Berger M (1995) Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy. J Hypertens 13: 933-938.
161. Schmidt-Nielsen B (1996) August and Marie Krogh - lives in science; 1st edn. Oxford University Press, inc., New York.
162. Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease: Evidence of genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165.
163. Sharma K, Ziyadeh FN (1995) Perspectives in diabetes. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor - as a key mediator. Diabetes 44: 4439-1146.
164. Shemesh O, Golbetz HV, Kriss JP, Myers BD (1985) Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28: 830-838.
165. Shoji T, Nishizawa Y, Toyokawa A, Kawagishi T, Okuno Y, Morii H (1991) Decreased albuminuria by pravastatin in hyperlipidemic diabetics. Nephron 59: 664-665.
166. Shultz PJ, Raij L (1990) Inhibition of human mesangial cell proliferation by calcium channel blockers. Hypertension 15: I-76-I-80.
167. Steffes MW, Brown DM, Mauer SM (1978) Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27: 35-41.
168. Steffes MW, Brown DM, Mauer SM (1979) The development, enhancement, and reversal of the secondary complications of diabetes mellitus. Hum Pathol 10: 293-299.
169. Stephenson J, Kenny S, Stevens LK, Fuller JH, Lee E, WHO Multinational Study Group (1995) Proteinuria and mortality in diabetes: the WHO multinational study of vascular disease in diabetes. Diabetic Med 12: 149-155.
170. Striker GE, Agodoa LL, Held P, Doi T, Conti FG, Striker LJ (1992) Kidney disease of diabetes mellitus (diabetic nephropathy): perspectives in the United States. J Diabet Complications 5: 51-52.
171. Striker GE, Peten EP, Carome MA, Pesce CM, Schmidt K, Yang C-W et al. (1993) The kidney disease of diabetes mellitus (KDDM): A cell and molecular biology approach. Diabetes Metab Rev 9: 37-56.
172. Sundhedsstyrelsens arbejdsgruppe vedrørende diabetesbehandling (1994) Diabetesbehandling i Danmark - fremtidig organisering; 1st edn. Sundhedsstyrelsen, Copenhagen.
173. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A (1994) Angiotensin converting enzyme inhibitor modulates golmerular function and structure by distinct mechanisms. Kidney Int 45: 537-543.
174. Tarnow L, Rossing P, Gall M-A, Nieisen FS, Parving H-H (1994) Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 17 (11): 1247-1251.
175. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L et al. (1995) Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44: 489-494.
176. Telmer S, Christiansen JS, Andersen AR, Nerup J, Deckert T (1984) Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 215: 63-68.
177. Terasaki PI, Cecka M, Gjertson DW, Takemoto S (1995) High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333: 333-336.
178. The Diabetes Control and Complications Trial Research Group. (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
179. The Diabetes Control and Complications Trial Research Group. (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 47: 1703-1720.
180. Thomas ME, Harris KPG, Ramaswamy C, Hattersley JM, Wheeler DC, Varghese Z et al. (1993) Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int 44: 1124-1129.
181. Tomlanovich S, Deen WM, Jones III HW, Schwartz HC, Myers BD (1987) Functional nature of glomerular injury in progressive diabetic glomerulopathy. Diabetes 36: 556-565.
182. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM et al. (1993) Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 91: 1269-1281.
183. van der Heide JJH, Bilo HJG, Donker JM, Wilmink JM, Tegzess AM (1993) Effect of dietary fish oil on renal function and rejection in
184. van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ et al. (1996) Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347: 94-95.
185. Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H (1983a) Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J 286: 598-602.
186. Viberti GC, Bilous RW, Mackintosh D, Keen H(1983b) Monitoring glomerular function in diabetic nephropathy. Am J Med 74: 256-264.
187. Viberti GC, Mackintosh D, Keen H (1983c) Determinants of the penetration of proteins through the glomerular barrier in insulin-dependent diabetes mellitus. Diabetes 32: 92-95.
188. Viberti GC, Mogensen CE, Groop L, Pauls JF, the European Micro-albuminuria Captopril Study Group (1994) Effect of Captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271: 275-279.
189. Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H et al. (1989) Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet ii: 1411-1415.
190. Wang PH, Lau J, Chalmers TC (1993) Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 341: 1306-1309.
191. Watkins PJ, Blainey JD, Brewer DB, Fitzgerald MG, Malins JM, O'Sullivan DJ et al. (1972) The natural history of diabetic renal disease. A follow-up study of series of renal biopsies. Q J Med 41: 437-456.
192. Weidmann P, Boehlen LM, de Courten M, Ferrari P (1992) Antihypertensive therapy in diabetic patients. Journal of Human Hypertension 6: S23-S36.
193. Williams PS, Foss G, Bone JM (1988) Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med 252: 343-354.
194. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R et al. (1995) Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96: 2162-2169.
195. Zatz R, Meyer TW, Rennke HG, Brenner BM (1985) Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82: 5963-5967.
196. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930.
197. Zatz R, Brenner BM (1986) Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med 80: 443-453.
198. Zeller KR, Whittaker E, Sullivan L, Raskin P, Jacobson HR (1991) Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes melitus. N Engl J Med 324: 78-84.
199. Zucchelli P, Zuccala A, Borghi M, Fusaroli M, Sasdelli M, Stallone C et al. (1992) Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 42: 452-458.
200. Østerby R (1993) Renal pathology in diabetes mellitus. Current Opinion in Nephrology and Hypertension 2: 475-483.